(CXSE) WisdomTree China - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US97717X7194 • China Region
CXSE: Chinese, Stocks, Companies, Ex-State-Owned
The WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ:CXSE) is designed to provide exposure to Chinese equities while excluding state-owned enterprises (SOEs). Under normal market conditions, the fund allocates at least 80% of its assets to securities that replicate the economic characteristics of its underlying index. This index is a modified float-adjusted market capitalization-weighted index, focusing on common stocks of Chinese companies, excluding those controlled by the state. By excluding SOEs, the fund targets companies that are more aligned with private-sector growth and less influenced by government ownership. The fund is classified as non-diversified, which allows it to invest a larger portion of its assets in a smaller number of securities, potentially increasing exposure to specific sectors or companies.
From a technical perspective, CXSE has shown upward momentum, with its last price of $34.31 exceeding both its 20-day ($32.69) and 50-day ($30.93) simple moving averages. The 200-day SMA stands at $29.38, indicating a longer-term upward trend. The Average True Range (ATR) of 0.60 suggests relatively low volatility, making it accessible for investors seeking stability. The funds average trading volume of 48,828 shares over the past 20 days reflects moderate liquidity. With assets under management (AUM) of $441.32 million, CXSE is a sizable ETF, offering a cost-effective way to access the Chinese market excluding state-owned enterprises.
Looking ahead, CXSE is expected to maintain its upward trajectory over the next three months, supported by its current technical momentum. The funds price could potentially test the $36.00 level, representing a 4.9% increase from its current price, as it moves toward its next resistance level. The relatively low ATR of 0.60 suggests that price fluctuations will remain manageable, with daily price movements likely staying within a narrow range. The funds focus on non-state-owned enterprises positions it to benefit from Chinas private-sector growth, which is anticipated to outperform state-owned counterparts in the near term. Investors seeking exposure to Chinas economic growth without the influence of state-owned enterprises may find CXSE an attractive option.
Additional Sources for CXSE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CXSE ETF Overview
Market Cap in USD | 386m |
Category | China Region |
TER | 0.32% |
IPO / Inception | 2012-09-19 |
CXSE ETF Ratings
Growth Rating | -19.0 |
Fundamental | - |
Dividend Rating | 42.4 |
Rel. Strength | 10.9 |
Analysts | - |
Fair Price Momentum | 29.82 USD |
Fair Price DCF | - |
CXSE Dividends
Dividend Yield 12m | 1.64% |
Yield on Cost 5y | 1.32% |
Annual Growth 5y | 7.41% |
Payout Consistency | 89.3% |
CXSE Growth Ratios
Growth Correlation 3m | 1.6% |
Growth Correlation 12m | 66.5% |
Growth Correlation 5y | -82.7% |
CAGR 5y | -3.59% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | -0.35 |
Alpha | 14.73 |
Beta | 0.614 |
Volatility | 37.34% |
Current Volume | 24.5k |
Average Volume 20d | 40.9k |
As of April 25, 2025, the stock is trading at USD 32.21 with a total of 24,461 shares traded.
Over the past week, the price has changed by +5.92%, over one month by -6.28%, over three months by +6.37% and over the past year by +22.22%.
Neither. Based on ValueRay Analyses, WisdomTree China is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -18.96 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CXSE as of April 2025 is 29.82. This means that CXSE is currently overvalued and has a potential downside of -7.42%.
WisdomTree China has no consensus analysts rating.
According to ValueRays Forecast Model, CXSE WisdomTree China will be worth about 33 in April 2026. The stock is currently trading at 32.21. This means that the stock has a potential upside of +2.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 33 | 2.3% |